Evidence map›Paper›PMID 32803562›Full record

ArticleDrug delivery and translational research2020

Physicochemical characterization and in vitro biological evaluation of solid compounds from furazolidone-based cyclodextrins for use as leishmanicidal agents.

Suzana Gonçalves Carvalho, Daniel Fernandes Cipriano, Jair Carlos Checon de Freitas, Miguel Ângelo Schettino Junior, Enrique Ronald Yapuchura Ocaris, Carolina Bioni Garcia Teles, Aurileya de Jesus Gouveia, Ricardo Pereira Rodrigues, Marcos Santos Zanini, Janaína Cecília Oliveira Villanova

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Suzana Gonçalves CarvalhoDepartment of Drugs and Medicines, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, SP, 14800-903, Brazil. suzana2994@gmail.com.ORCID 0000-0002-0139-457X
Daniel Fernandes CiprianoLaboratory of Carbon and Ceramic Materials, Department of Physics, Federal University of Espírito Santo (UFES), Vitória, ES, 29075-910, Brazil.
Jair Carlos Checon de FreitasLaboratory of Carbon and Ceramic Materials, Department of Physics, Federal University of Espírito Santo (UFES), Vitória, ES, 29075-910, Brazil.
Miguel Ângelo Schettino JuniorLaboratory of Carbon and Ceramic Materials, Department of Physics, Federal University of Espírito Santo (UFES), Vitória, ES, 29075-910, Brazil.
Enrique Ronald Yapuchura OcarisLaboratory of Carbon and Ceramic Materials, Department of Physics, Federal University of Espírito Santo (UFES), Vitória, ES, 29075-910, Brazil.
Carolina Bioni Garcia TelesMalaria and Leishmaniasis Bioassay Platform (PBML), Oswaldo Cruz Foundation Rondônia (FIOCRUZ), Porto Velho, Rondônia, Brazil.
Aurileya de Jesus GouveiaMalaria and Leishmaniasis Bioassay Platform (PBML), Oswaldo Cruz Foundation Rondônia (FIOCRUZ), Porto Velho, Rondônia, Brazil.
Ricardo Pereira RodriguesGraduate Program in Pharmaceutical Sciences, Federal University of Espírito Santo (UFES), Vitória, ES, 29043-900, Brazil.
Marcos Santos ZaniniPostgraduate Program in Veterinary Sciences, Department of Veterinary Sciences, Federal University of Espírito Santo (UFES), Alegre, ES, 29500-000, Brazil.
Janaína Cecília Oliveira VillanovaPostgraduate Program in Veterinary Sciences, Department of Veterinary Sciences, Federal University of Espírito Santo (UFES), Alegre, ES, 29500-000, Brazil.
Universidade Federal do Espírito Santo · BRCentro Universitário de Araraquara · BRFundação Oswaldo Cruz · BRUniversidade Federal de Rondônia · BR

Funding

Fundação Estadual de Amparo à Pesquisa do Estado do Espírito Santo #201/2019Fundo de Amparo à Pesquisa FAP/UFES/2015
6 · The paper itself

Abstract

The discovery of new drugs and dosage forms for the treatment of neglected tropical diseases, such as human and animal leishmaniasis, is gaining interest in the chemical, biological, pharmaceutical, and medical fields. Many pharmaceutical companies are exploring the use of old drugs to establishing new drug dosage forms and drug delivery systems, in particular for use in neglected diseases. The formation of complexes with cyclodextrins is widely used to improve the stability, solubility, and bioavailability of pharmaceutical drugs, as well as reduce both the toxicity and side effects of many of these drugs. The aim of this study was to characterize solid compounds obtained from the association between furazolidone (FZD) and β-cyclodextrin (β-CD) or hydroxypropyl-β-cyclodextrin (HP-β-CD). The solid compounds were prepared in molar ratios of 1:1 and 1:2 (drug:CD) by kneading and lyophilization. Molecular docking was used to predict the preferred relative orientation of FZD when bound in both studied cyclodextrins. The resulting solid compounds were qualitatively characterized by scanning electron microscopy (SEM), thermal analysis (DSC and TG/DTG), X-ray diffraction (XRD), Raman spectroscopy with image mapping (Raman mapping), and

Indexed as

beta-CyclodextrinsFurazolidone2-Hydroxypropyl-beta-cyclodextrinAntiprotozoal AgentsCalorimetry, Differential ScanningLeishmaniaMolecular Docking SimulationSolubilitySpectroscopy, Fourier Transform InfraredX-Ray Diffraction2-Hydroxypropyl-beta-cyclodextrinAntiprotozoal Agentsbeta-CyclodextrinsFurazolidone2-Hydroxypropyl-β-cyclodextrinInclusion complexesLeishmanicidal activityNon-complexesβ-Cyclodextrin

Identifiers

PMID32803562
OpenAlexW3049080837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.